| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
20,162 |
14,551 |
$1.63M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,059 |
1,994 |
$430K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,065 |
671 |
$64K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,266 |
1,257 |
$59K |
| 80053 |
Comprehensive metabolic panel |
3,484 |
3,255 |
$34K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
347 |
347 |
$28K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,540 |
2,942 |
$24K |
| 36415 |
Collection of venous blood by venipuncture |
4,651 |
3,749 |
$21K |
| 71045 |
Radiologic examination, chest; single view |
1,334 |
1,261 |
$14K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
62 |
59 |
$13K |
| 70450 |
Computed tomography, head or brain; without contrast material |
218 |
215 |
$10K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
93 |
92 |
$10K |
| 80305 |
|
723 |
711 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
521 |
259 |
$7K |
| 81001 |
|
2,129 |
2,075 |
$6K |
| 84484 |
|
514 |
371 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
394 |
386 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
141 |
111 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
101 |
99 |
$4K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
37 |
37 |
$4K |
| 82553 |
|
351 |
253 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
97 |
97 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
43 |
39 |
$3K |
| 83880 |
|
82 |
70 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
332 |
204 |
$3K |
| 96367 |
|
28 |
13 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
56 |
55 |
$2K |
| 82550 |
|
417 |
304 |
$2K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
12 |
12 |
$2K |
| 83690 |
|
377 |
346 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
367 |
293 |
$2K |
| 83735 |
|
372 |
347 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
36 |
36 |
$2K |
| 84439 |
|
239 |
231 |
$2K |
| 82150 |
|
316 |
278 |
$2K |
| 80061 |
Lipid panel |
117 |
117 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
139 |
139 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
58 |
57 |
$815.13 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
24 |
12 |
$782.85 |
| 82977 |
|
118 |
109 |
$729.25 |
| 81025 |
|
84 |
84 |
$572.85 |
| 82465 |
|
107 |
103 |
$374.73 |
| 85027 |
|
35 |
26 |
$201.25 |
| 71046 |
Radiologic examination, chest; 2 views |
13 |
13 |
$179.98 |
| 85610 |
|
39 |
37 |
$129.96 |
| 85007 |
|
35 |
26 |
$118.30 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
19 |
13 |
$7.56 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
16 |
14 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
171 |
136 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
21 |
12 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
29 |
13 |
$0.00 |